In vitro and in vivo antimycobacterial activity of antiinflammatory drug, diclofenac sodium

Indian Journal of Experimental Biology

Volumn 42, Issue 9, 2004, Pages 922-927

  Dutta, N K ^a   Kumar, K Asok ^a   Mazumdar, Kaushiki ^a   Dastidar, Sujata G ^a   Ray, R ^b   Chakrabarty, A N ^b  

^a JADAVPUR UNIVERSITY   (India)

^b UNIVERSITY OF CALCUTTA   (India)

Author keywords

Antiinflammatory drug; Antimycobacterial activity; Diclofenac sodium

Indexed keywords

ANTIINFLAMMATORY DRUGS; DRUG RESISTANCE; STEROIDS; TUBERCULOSIS;

BACTERIA; BIOLOGY; CLINICAL LABORATORIES; CONCENTRATION (PROCESS); DRUG DOSAGE; STRAIN;

DRUG PRODUCTS;

ANTIINFECTIVE AGENT; DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ARTICLE; DRUG EFFECT; IN VITRO STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; MALE; MICE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS;

ANIMALIA; CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 4444233305     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Molnár J, Beladi I & Foldes I, Studies on antitubercular action of some phenothiazine derivatives in vitro, Zbl Bakt Hyg I Abt Orig A, 239 (1977) 521.
2. Crowle AJ, Douvas GS & May MH, Chlorpromazine: A drug potentially useful for treating mycobacterial infections, Chemother, 38 (1992) 410.
3. Ratnakar P & Murthy PS, Antitubercular activity of trifluoperazine, a calmodulin antagonist, FEMS Microbiology letters, 76 (1992) 73.
4. Chakrabarty AN, Bhattacharya CP & Dastidar SG, Antimycobacterial activity of methdilazine (Md), an antimicrobic phenothiazine, Acta Path Microbiol Immun Scand, 101 (1993) 449.
5. Amaral L, Kristiansen JE, Abebe LS & Millet W, Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: Potential use for initial therapy of freshly diagnosed tuberculosis, J Antimicrob Chemother, 38 (1996) 1049.
6. Kristiansen JE & Vergman B, Antibacterial effect of selected phenothiazines and thioxanthines on slow growing mycobacteria, Acta Path Microbiol Immun Scand, 94 (1986) 393.
7. Kristiansen JE, The antimicrobial activity of non-antibiotics, Acta Path Microbiol Scand, 100 Suppl. (1992) 7.
8. Mazumdar R, Ganguly K, Dastidar SG & Chakrabarty AN, Trifluoperazine: A broad-spectrum bactericide specially active on staphylococci and vibrios, Int J Antimicrob Agents, 18 (2001) 403.
9. Molnár J, Mandi Y & Király J, Antibacterial effect of some phenothiazine compounds and the R-factor elimination by chlorpromazine, Acta Microbiol Acad Sci Hung, 23 (1976) 45.
10. Annadurai S, Basu S, Ray S, Dastidar SG & Chakrabarty AN, Antimicrobial activity of the antiinflammatory agent diclofenac sodium, Indian J Exp Biol, 36 (1998) 86.
11. Dastidar SG, Basu S, Annadurai S & Chakrabarty AN, In vitro and in vivo antibacterial activity of the antiinflammatory agent diclofenac sodium, in Recent advances in chemotherapy, Proceedings of the Eighteenth International Congress of Chemotherapy, Stockholm, Sweden, 1994, 339.
12. Kirchner O, Die Leistungsfahigkeit der Tiefenkultur des Tuberkelbazillus bei Verwendung besonders geeigneter flussiger Nahrboden, Zentralblat fur Bakt, 124 (1932) 403.
13. Oberhofer TR, Manual of practical medical microbiology and parasitology (John Wiley and Sons, Toronto) 1985, 352.
14. Dickinsion JM & Mitchison DA, In vitro property of rifapentine (MDL 473) relevant to its use in the intermittent chemotherapy of tuberculosis, Tubercule, 1987, 113.
15. Fenner F, The pathogenic behavior of Mycobacterium ulcerans and Mycobacterium balnei in the mouse and the developing chick embryo, Am Rev Tubercul, 73 (1956) 650.
16. Wilson GS & Miles AA, in Topley and Wilson's principles of bacteriology and immunity, Vol 1 (Edward Arnold, London) 1975, 588.
17. Dastidar SG, Ganguly K, Chaudhuri K & Chakrabarty AN, The antibacterial action of diclofenac shown by inhibition of DNA synthesis, Int J Antimicrob Agents, 14 (2000) 249.
18. Amaral L & Kristiansen JE, Phenothiazines. An alternative to conventional management of suspect multi-drug resistant tuberculosis. A call for studies, Int J Antimicrob Agents, 14 (2000) 173.
19. Dutta NK, Mazumdar K, Kumar AK & Dastidar SG, Studies on antimycobacterial activity of the antiinflammatory agent diclofenac sodium, and its synergism with streptomycin; Abstract Book of XXVIIth Annual Congress of Indian Association of Medical Microbiologists, 2003, 58.
20. Goodman Gilman A, Goodman and Gilman's the pharmacological basis of therapeutics, Vol. I and Vol. II, edited by J.G. Hardman J.G., L.E Limbird and A Goodman Gilman (McGraw- Hill, New York) 2001.